Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Pro. Gr. - PA: Inst. of Musculoskeletal Health and Arthritis: IMHA Mandate Areas

University of Ottawa

$100,000.00

Characterizing the implication and therapeutic potential of AMPK signaling in Myotonic Dystrophy Type 1 (DM1)

FY 2025-26

Summary
Myotonic Dystrophy type 1 (DM1) is caused by a mutation affecting the normal function of cells, causing the many symptoms characteristic of this disease. Our research led us to investigate AMPK signaling in DM1 skeletal muscle cells. We recently found that AMPK signaling is altered in DM1 muscle cells, and that the activation of AMPK with drugs and exercise is beneficial for the muscle pathology. Furthermore, we also identified that the RNA-binding protein HuR is impacted by the altered AMPK signaling and that it plays a direct role in the regulation of genes affected in DM1. Here, we will build upon these initial findings and investigate the role of AMPK in DM1 skeletal muscle and determine the contribution of HuR in the DM1 disease progression. The characterization of this pathway appears crucial and timely as this study will pave the way to a better understanding of the DM1 muscle pathology while leading to the development of novel therapeutics for DM1.
Program
Pro. Gr. - PA: Inst. of Musculoskeletal Health and Arthritis: IMHA Mandate Areas
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
553960
Name
Jasmin Bernard J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Characterizing the implication and therapeutic potential of AMPK signaling in Myotonic Dystrophy Type 1 (DM1)
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Pro. Gr. - PA: Inst. of Musculoskeletal Health and Arthritis: IMHA Mandate Areas
Keyworddelim
Alternative Splicing; Ampk Signalling; Exercise; Myotonic Dystrophy Type 1; Neuromuscular Disease; Pharmacological; Preclinical; Rna Binding Proteins; Skeletal Muscle; Therapeutic
Abstract
Myotonic Dystrophy type 1 (DM1) is caused by a mutation affecting the normal function of cells, causing the many symptoms characteristic of this disease. Our research led us to investigate AMPK signaling in DM1 skeletal muscle cells. We recently found that AMPK signaling is altered in DM1 muscle cells, and that the activation of AMPK with drugs and exercise is beneficial for the muscle pathology. Furthermore, we also identified that the RNA-binding protein HuR is impacted by the altered AMPK signaling and that it plays a direct role in the regulation of genes affected in DM1. Here, we will build upon these initial findings and investigate the role of AMPK in DM1 skeletal muscle and determine the contribution of HuR in the DM1 disease progression. The characterization of this pathway appears crucial and timely as this study will pave the way to a better understanding of the DM1 muscle pathology while leading to the development of novel therapeutics for DM1.
Competitiondate
202509
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jasmin, Bernard J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Ottawa - $100,000 Grant (2025-26) | Canada Spends